Regeneron Pharmaceuticals Development Agreements
4 Contracts & Agreements
- Amended and Restated Immuno-oncology Discovery and Development Agreement, executed on January 2, 2019 and effective as of December 31, 2018, by and between the Registrant and... (Filed With SEC on February 7, 2019)
- AMENDMENT NO. 1 TO AMENDED AND RESTATED DISCOVERY AND PRECLINICAL DEVELOPMENT AGREEMENT (Filed With SEC on November 4, 2015)
- AMENDED AND RESTATEDDISCOVERY AND PRECLINICAL DEVELOPMENT AGREEMENT By and Between AVENTIS PHARMACEUTICALSINC. and REGENERON PHARMACEUTICALS,INC. Dated as of November 10, 2009... (Filed With SEC on February 18, 2010)
- DISCOVERY AND PRECLINICAL DEVELOPMENT AGREEMENT (Filed With SEC on February 27, 2008)